Sangüesa, E.; Fernández-Egea, E.; Concha, J.; García, C.B.; Ribate, M.P.
Impact of Pharmacogenetic Testing on Clozapine Treatment Efficacy in Patients with Treatment-Resistant Schizophrenia. Biomedicines 2024, 12, 597.
https://doi.org/10.3390/biomedicines12030597
AMA Style
Sangüesa E, Fernández-Egea E, Concha J, García CB, Ribate MP.
Impact of Pharmacogenetic Testing on Clozapine Treatment Efficacy in Patients with Treatment-Resistant Schizophrenia. Biomedicines. 2024; 12(3):597.
https://doi.org/10.3390/biomedicines12030597
Chicago/Turabian Style
Sangüesa, Estela, Emilio Fernández-Egea, Julia Concha, Cristina B. García, and María Pilar Ribate.
2024. "Impact of Pharmacogenetic Testing on Clozapine Treatment Efficacy in Patients with Treatment-Resistant Schizophrenia" Biomedicines 12, no. 3: 597.
https://doi.org/10.3390/biomedicines12030597
APA Style
Sangüesa, E., Fernández-Egea, E., Concha, J., García, C. B., & Ribate, M. P.
(2024). Impact of Pharmacogenetic Testing on Clozapine Treatment Efficacy in Patients with Treatment-Resistant Schizophrenia. Biomedicines, 12(3), 597.
https://doi.org/10.3390/biomedicines12030597